5-Bromo-4-methylpyridazin-3-amine

5-Bromo-4-methylpyridazin-3-amine (CAS 1638759-55-3) is a pharmaceutical-grade intermediate manufactured directly by Shanghai Rlavie Technology Co., Ltd at a minimum purity of 98%, with COA, HNMR, and HPLC/GC documentation available on request. It is produced to a broad range of pharmacopoeia standards, including ChP, USP, BP, EP, JP, Ph.Int., and IP, and sold across North America, Central/South America, Europe, Australasia, Asia, the Middle East, and Africa.